CS-3150
CS3150-B-J204
Phase 2 small_molecule completed
Quick answer
CS-3150 for Diabetic Nephropathy is a Phase 2 program (small_molecule) at Daiichi Sankyo with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Daiichi Sankyo
- Indication
- Diabetic Nephropathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed